Download logo
As of today, the cumulative number of confirmed COVID-19 cases in South Africa is 76 334.
Case Data:
| Province | Total cases for 16 June 2020 | Percentage total |
| Eastern Cape | 11039 | 14,5 |
| Free State | 578 | 0,8 |
| Gauteng | 13023 | 17,1 |
| KwaZulu-Natal | 4048 | 5,3 |
| Limpopo | 391 | 0,5 |
| Mpumalanga | 343 | 0,4 |
| North West | 1281 | 1,7 |
| Northern Cape | 211 | 0,3 |
| Western Cape | 45357 | 59,4 |
| Unknown | 63 | 0,1 |
| Total | 76334 | 100,0 |
Reported COVID-19 Deaths and Recoveries:
Regrettably, we report a further 57 COVID-19 related deaths: 44 from Western Cape, 9 from the Eastern Cape, and 4 from KwaZulu Natal.
This brings the total national deaths to 1625 with a mortality rate of 2.1%.
We extend our condolences to the loved ones of the departed and thank the health care workers who treated the deceased.
The recoveries to date are 42 063 – this translates to a recovery rate of 55.1%.
The provincial breakdown is as follows:
| Province | Deaths | Recoveries |
| Eastern Cape | 245 | 5475 |
| Free State | 9 | 222 |
| Gauteng | 87 | 3442 |
| KwaZulu Natal | 73 | 2133 |
| Limpopo | 4 | 213 |
| Mpumalanga | 1 | 138 |
| North West | 5 | 152 |
| Northern Cape | 1 | 52 |
| Western Cape | 1200 | 30236 |
| Total | 1625 | 42063 |
Breakthrough in COVID-19 therapeutics research
We are extremely excited that there has been an important breakthrough in one of the therapeutic trials for COVID-19 management.
The RECOVERY (Randomised Evaluation of COVID-19 therapy) trial has published results on the therapeutic merits of low dose dexamethasone which are extremely promising and are easily implementable in our country Dexamethasone is a well known and widely used steroid which has potent anti-inflammatory properties. It is used in allergic reactions, asthma and other conditions where the inflammatory component of the disease needs to be controlled for better outcomes.
We are very pleased that the Ministerial Advisory Committee on COVID-19 has issued an advisory pertaining to the clinical applications of these breaking study results. We attach the advisory to this statement.
Issued by: Department of Health
Distributed by APO Group on behalf of South African Government.
